World Targeted Therapeutics Summit South Korea 소개
Three Events. One Connected Experience.
Antibody-drug conjugates, targeted protein degradation, induced proximity, bispecifics, and T-Cell Engagers have fast become the leading focus of R&D emerging from South Korea. The World Targeted Therapeutics South Korea Summit by Hanson Wade is a brand-new event experience delivering a comprehensive three-day coverage of the hottest topics in oncology by uniting three conferences together in the same venue at the same time: the 5th World ADC South Korea Summit, the World TPD & Induced Proximity Summit South Korea, and the World Bispecific & T-Cell Engager Summit South Korea.
This is a unique opportunity to focus on differentiated platforms and pipelines to create future first-and-best-in-class therapeutics that make you stand out from your competition and more appealing for global pharma partnerships.
Acting as Korea's most comprehensive R&D forum, join 450+ of your peers to transform the future and position South Korea as a global leader in targeted therapeutic R&D with both a strategic overview and technical insights across discovery, preclinical translation, clinical development, and manufacturing in each field.
What to Expect?
참가자 혜택
Cross-Modality Scientific Insight:
Whether you work on antibody-drug conjugates (ADCs), targeted protein degradation (TPD) and induced proximity, bispecifics, or T-cell engagers, gain a holistic view of how to develop next-generation targeted therapeutics.
Translational & Clinical Learnings:
Access real-world case studies and clinical data from early discovery through late-stage development, with a focus on overcoming shared challenges in efficacy, safety, and patient selection.
Strategic Partnering & Innovation Opportunities:
Connect with Korean and global pharma, biotech, and solution providers across all three modalities to identify collaboration opportunities, technology platforms, and novel combination approaches.
Future-Facing Perspectives:
Hear from industry leaders on emerging trends, regulatory considerations, and the long-term commercial outlook shaping the next era of targeted therapies.
Event Highlights
행사 주요 내용
5th World ADC South Korea Summit
With 16 years of experience providing antibody-drug conjugate focused conferences around the world, and 5 years in the APAC region, World ADC Asia is your one-stop shop for ADC content from early discovery to late-phase manufacturing.
Learn, Share, Collaborate to Direct the Future Korean ADC Development
World Bispecifics & T-Cell Engager Summit South Korea
With 16 years of experience providing bispecific conferences around the world, the World Bispecifics & T-Cell Engager Summit comes to the APAC region to unite a community keen to create and develop differentiated bispecific drugs.
Supercharge Bispecific & TCEs to Revolutionize Oncology Treatments
World TPD & Induced Proximity Summit South Korea
With 8 years of experience providing targeted protein degradation-focused conferences around the world, the TPD & Induced Proximity Summit comes to the APAC region to unite a community keen to stay ahead in the evolving induced proximity landscape and develop novel degradation platforms that redefine the druggable proteome.
Your One-Stop Forum to De-Risk & Develop Best-in-Class TPD Therapeutics